RxDoctor Payments Data

Crystal Luke, MD

Family Medicine · Sylvania, OHNPI 1174575096

Payments from drug & device makers

$1,897in general payments, 2019–2025

Across 111 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$292
  • Boehringer Ingelheim$246
  • GSK$220
  • Novo Nordisk$196
  • Exact Sciences$182
  • Amgen$103
  • plus $659 from 11 others

What the payments were for

  • Food & beverage$1,897100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,897 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$69,880
Medicare patients
120
Services billed
631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin84$107,219
TrulicityDulaglutide64$86,281
JanuviaSitagliptin Phosphate62$75,019
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$43,756
OzempicSemaglutide26$38,708
FarxigaDapagliflozin Propanediol27$29,102
MounjaroTirzepatide21$27,119
Tresiba Flextouch U-200Insulin Degludec13$22,543
TradjentaLinagliptin13$20,351
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$19,564
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog22$10,128
Candesartan Cilexetil136$9,129
Verapamil SrVerapamil Hcl28$6,258
JanumetSitagliptin Phos/Metformin Hcl13$4,749
Rosuvastatin Calcium285$4,313

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$246$127,57097 claims
Lilly USA, LLCTrulicity, Mounjaro$61$113,39985 claims
MerckJanuvia, Janumet$42$79,76875 claims
GSKTrelegy Ellipta, Anoro Ellipta$220$63,32067 claims
Novo NordiskOzempic$196$38,70826 claims
AstraZenecaFarxiga$292$29,10227 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Sylvania

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →